Interim results due this month won't be 'strong' volume didn't pick up until after end of December, revenue already disclosed as $1.72m.
If Gm% is 70%, GM $1.2m & overheads around $1.6-$1.7m, result likely to be around -$0.5m /-$0.6m depending on investment in overheads.
Q3 announcement in mid April is when the impact of increase in demand will show in results, although expect further commentary in post balance sheet events in in terms.
- Forums
- ASX - By Stock
- ZNO
- Ann: Coronavirus Update
Ann: Coronavirus Update, page-439
-
- There are more pages in this discussion • 227 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZNO (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.536M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 398386 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 873 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 398386 | 0.027 |
3 | 83360 | 0.026 |
3 | 198000 | 0.025 |
5 | 440117 | 0.024 |
1 | 70000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 873 | 1 |
0.030 | 351595 | 1 |
0.031 | 103180 | 1 |
0.033 | 90909 | 1 |
0.035 | 27000 | 1 |
Last trade - 11.00am 16/07/2024 (20 minute delay) ? |
Featured News
ZNO (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online